«Iga Deficiency

Below is an extended Iga Deficiency patents listing. Click here to return to the Iga Deficiency main in depth entry.

Patents :
US Patent No.	Title
7060479	Full-length human cDNAs encoding potentially secreted proteins
7163797	50 human secreted proteins
7164004	Human tumor necrosis factor TR20 and methods based thereon
7166428	62112, a novel human dehydrogenase and uses thereof
7175988	Human G-protein Chemokine Receptor (CCR5) HDGNR10
7189690	Albumin fusion proteins
7189820	Antibodies against tumor necrosis factor delta (APRIL)
7196164	Secreted protein HHTLF25
7202056	Polynucleotides encoding a human cell surface protein with immunoglobulin folds, BGS-19
7211258	Protein A compositions and methods of use
7217788	Human tumor necrosis factor delta polypeptides
7160986	BCL-x.gamma., a novel BCL-x isoform, and uses related thereto
7160541	Modified polypeptides stabilized in a desired conformation and methods for producing same
7141547	Albumin fusion proteins comprising GLP-1 polypeptides
7078027	Human endokine alpha
7078186	Apoptosis related polynucleotides, polypeptides, and antibodies
7083966	Cytidine deaminase
7091315	Protein HDPBQ71
7094587	16002 Molecules and uses therefor
7101962	Antibodies of the P2Y10 receptor useful in altering T lymphocyte function
7112410	Human tumor necrosis factor TR21 and methods based thereon
7112440	Method of increasing the relative number of CD45 low cells in a cell population
7128906	T1 receptor-like ligand II and uses thereof
7138501	Antibodies that immunospecifically bind BLyS
7220412	Method of preparing an undifferentiated cell
7220840	Antibodies that immunospecifically bind to B lymphocyte stimulator protein
7361480	Method and means for detecting gluten-induced diseases
7368527	HADDE71 polypeptides
7368531	Human secreted proteins
7371383	Recombinant anti-interleukin-9 antibodies
7371388	Treatment of Sjogren's syndrome by administration of TR18 polypeptides
7375192	Antibodies that specifically bind to chemokine beta-4
7381800	Antibodies to HBIMF63 polypeptide
7390637	Keratinocyte derived interferon
7393934	Human G-protein chemokine receptor (CCR5) HDGNR10
7410773	Method of preparing an undifferentiated cell
7351566	27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552, and 65577 molecules and uses therefor
7314621	Cytidine deaminase
7312051	Polynucleotides encoding dendritic enriched secreted lymphocyte activation molecule
7223558	Polynucleotides encoding three novel human cell surface proteins with leucine rich repeats and immunologobulin folds, BGS2, 3, and 4 and variants thereof
7226791	Polynucleotides encoding novel guanylate binding proteins (GBP's)
7232667	Keratinocyte growth factor-2 polynucleotides
7238660	Albumin fusion proteins
7238667	Albumin fusion proteins
7241869	Modified polypeptides stabilized in a desired conformation and methods for producing same
7247442	Antibodies to HHPEN62 polypeptide
7258994	Saliva immunoassay for detection of antibodies for cardiovascular disease
7264926	Nucleoside Phosphatase
7271243	Full-length human cDNAs encoding potentially secreted proteins
7411051	Antibodies to HDPPA04 polypeptide

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.